 SOUTH SAN FRANCISCO, Calif., Nov. 11, 2021 GLOBE NEWSWIRE -- Imago BioSciences, Inc. Imago Nasdaq: IMGO, a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms MPNs, today announced that Hugh Y. Rienhoff, Jr., M.D., Imagos Chief Executive Officer, will present at the Stifel 2021 Virtual Healthcare Conference on Tuesday, November 16, 2021, at 10:40 a.m. ET. 